Wire-guided localization (WGL) |
Well-established
Cost-effective
Marker placement under radiographic, ultrasound or MRI guidance possible → suitable for localization of lesions visible only upon mammography (e.g., microcalcifications) or MRI
Control mammogram or MRI after wire placement possible
Reposition in case of some wires possible
|
|
Radioactive seed localization (RSL) |
Well-established
Scheduling flexibility: localization can be performed several days/weeks before surgery or—in case of neoadjuvant therapy—before start of treatment
Marker placement under radiographic or ultrasound guidance possible → suitable for localization of lesions visible only upon mammography (e.g., microcalcifications)
Control mammogram after marker placement possible
Can be combined with isotope-based sentinel node biopsy
|
Procedure not authorized in some countries, requires complex radiation safety procedures
Radiation exposure to patient and staff
Invasive procedure for marker placement necessary
In case of marker placement before neoadjuvant therapy signal loss possible in case of longer than planned duration of therapy
Reposition after placement not possible
Radiation safety concerns regarding MRI-guided localization (Geiger counter is MRI unsafe and cannot be used in case of seed loss in Zone IV)
Very low risk of seed rupture or transection, resulting in emergency treatment with iodine to saturate and safeguard the thyroid gland in case of 125I
|
Radio-guided Occult Lesion Localization (ROLL) |
|
Scheduling issues: procedure needs to be performed on the day of surgery or the day before
Radiation safety procedures required
Potential radiation exposure to patient and staff
Invasive preoperative procedure necessary
Reposition after placement not possible
Control mammogram not possible unless contrast also given
|
Magnetic and paramagnetic localization Commercially available systems:
|
No radioactivity involved
Marker placement under radiographic or ultrasound guidance possible → suitable for localization of lesions visible only upon mammography (e.g., microcalcifications)
Scheduling flexibility: localization can be performed several days/weeks before surgery or—in case of neoadjuvant therapy—before start of treatment
No decrease of signal over time → reliable detectability in case of longer than planned neoadjuvant therapy
Control mammogram after marker placement possible
Can be combined with magnetic tracer for sentinel node biopsy
|
Concerns regarding use in patients with pacemakers and implantable defibrillators
Standard metal surgical tools may lead to interference during measurement
Large MRI artifacts
Not suitable for lesions visible only upon MRI
Higher device cost
Adequate localization may be limited in case of a large distance between marker and detection probe
Reposition after placement not possible
|
Radar reflector-based localization Commercially available systems:
|
No radioactivity involved
Minimal MRI artifact
Marker placement under radiographic or ultrasound guidance possible → suitable for localization of lesions visible only upon mammography (e.g., microcalcifications)
Scheduling flexibility: localization can be performed several days/weeks before surgery or—in case of neoadjuvant therapy—before start of treatment
No decrease of signal over time → reliable detectability in case of longer than planned neoadjuvant therapy
Control mammogram after marker placement possible
|
Potential signal interference with lights in the operating theatre
Small MRI artifacts
Not suitable for lesions visible only upon MRI
Higher device cost
Adequate localization may be limited in case of a large distance between marker and detection probe
Reposition after placement not possible
|
Radiofrequency identification tags (RFID) Commercially available systems:
|
No radioactivity involved
Scheduling flexibility: localization can be performed several days/weeks before surgery or—in case of neoadjuvant therapy—before start of treatment
Marker placement under radiographic or ultrasound guidance possible → suitable for localization of lesions visible only upon mammography (e.g., microcalcifications)
No decrease of signal over time → reliable detectability in case of longer than planned neoadjuvant therapy
Unique tag number → differentiation between tags possible
Control mammogram after marker placement possible
|
Concerns regarding use in patients with pacemakers and implantable defibrillators
MRI artifacts
Not suitable for lesions visible only upon MRI
Higher device cost
Adequate localization may be limited in case of a large distance between marker and detection probe
Reposition after placement not possible
|
Intraoperative ultrasound (IOUS) |
Direct visualization during surgery
No radioactivity involved
Patient friendly (non-invasive)
No preoperative invasive procedure necessary → scheduling flexibility
Specimen sonography is performed immediately after tissue removal → no time loss due to specimen transport
Specimen sonography performed in the operating room → exact and reliable topographic localization of close margins for immediate re-excision
Relatively low cost
|
Surgeon needs to be experienced in breast ultrasound, otherwise radiologist’s presence in the operating theatre necessary
Learning curve
Useful only for lesions with good sonographic visibility
Not suitable for lesions visible only upon mammography (e.g., microcalcifications) or MRI
Use in the neoadjuvant setting limited in case of complete remission due to low sonographic visibility of some tissue markers
Ultrasound machine must be available in the operating theatre during surgery
Some ultrasound machines available in operating theatres are unsuitable for breast ultrasound (frequency, transducer type) or of a much lower quality than machines in the diagnostics department
Radiogram showing lesion and marker not possible
|
Carbon |
No radioactivity involved
Low cost
Scheduling flexibility: localization can be performed several days/weeks before surgery or—in case of neoadjuvant therapy—before start of treatment
Marker placement under radiographic or ultrasound guidance possible
No MRI artifacts
|
Marker cannot be localized without surgical exploration
Possible ink migration
Intentional or unintentional tattooing of skin
Reposition after placement not possible
Control mammogram not possible
|